NO20025720L - Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet - Google Patents
Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitetInfo
- Publication number
- NO20025720L NO20025720L NO20025720A NO20025720A NO20025720L NO 20025720 L NO20025720 L NO 20025720L NO 20025720 A NO20025720 A NO 20025720A NO 20025720 A NO20025720 A NO 20025720A NO 20025720 L NO20025720 L NO 20025720L
- Authority
- NO
- Norway
- Prior art keywords
- antifungal
- antibacterial
- antitumor activity
- new compounds
- antitumor
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21447800P | 2000-06-27 | 2000-06-27 | |
| PCT/US2001/020334 WO2002000650A2 (fr) | 2000-06-27 | 2001-06-26 | Nouveaux composes possedant une activite anti-bacterienne, antifongique et anti-tumeur |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025720D0 NO20025720D0 (no) | 2002-11-28 |
| NO20025720L true NO20025720L (no) | 2003-02-26 |
Family
ID=22799223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025720A NO20025720L (no) | 2000-06-27 | 2002-11-28 | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6849713B2 (fr) |
| EP (1) | EP1294713A2 (fr) |
| JP (1) | JP2004501915A (fr) |
| KR (1) | KR20030011371A (fr) |
| CN (1) | CN1439006A (fr) |
| AU (1) | AU2001270183A1 (fr) |
| BR (1) | BR0112030A (fr) |
| CA (1) | CA2414512A1 (fr) |
| IL (1) | IL153119A0 (fr) |
| MX (1) | MXPA02012271A (fr) |
| NO (1) | NO20025720L (fr) |
| NZ (1) | NZ522839A (fr) |
| RU (1) | RU2003101969A (fr) |
| WO (1) | WO2002000650A2 (fr) |
| ZA (1) | ZA200209774B (fr) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002088119A1 (fr) | 2001-04-26 | 2002-11-07 | Genesoft Pharmaceuticals, Inc | Composes de thienyle a substitution halogene |
| EP1470119A4 (fr) | 2001-06-13 | 2005-10-19 | Genesoft Pharmaceuticals Inc | Composes benzothiophene presentant une activite anti-infectieuse |
| US20030236198A1 (en) | 2001-06-13 | 2003-12-25 | Genesoft, Inc. | Antipathogenic benzamide compounds |
| ITTO20010633A1 (it) * | 2001-07-02 | 2003-01-02 | Univ Ferrara | Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a. |
| GB0130868D0 (en) | 2001-12-24 | 2002-02-06 | Univ Strathclyde | New compounds |
| BR0207583A (pt) * | 2001-12-26 | 2004-04-27 | Genelabs Tech Inc | Derivados de poliamida possuindo atividade antibacteriana, antifungo ou antitumor |
| ITMI20021455A1 (it) * | 2002-07-02 | 2004-01-02 | Ugo Raffaello Citernesi | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
| ATE425753T1 (de) | 2002-08-02 | 2009-04-15 | Genesoft Pharmaceuticals Inc | Biaryl-verbindungen mit antiinfektiver wirkung |
| AU2003275225A1 (en) * | 2002-09-20 | 2004-04-08 | Genelabs Technologies, Inc. | Novel aromatic compounds possessing antifungal or antibacterial activity |
| WO2004035571A1 (fr) * | 2002-10-15 | 2004-04-29 | Rigel Pharmaceuticals, Inc. | Indoles substitues et leur utilisation en tant qu'inhibiteurs du virus de l'hepatite c (vhc) |
| EP1562931A2 (fr) | 2002-10-25 | 2005-08-17 | Genesoft Pharmaceuticals, Inc. | Composes biaryle anti-infectieux |
| JP2006509027A (ja) | 2002-12-10 | 2006-03-16 | オーシェント ファーマシューティカルズ コーポレーション | （ピロールカルボキサミド）−（ベンズアミド）−（イミダゾールカルボキサミド）モチーフを有する抗菌化合物 |
| EP1633349A1 (fr) * | 2003-05-02 | 2006-03-15 | Elan Pharmaceuticals, Inc. | Derives amide 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-acide carboxylique (1-(aminocarbonyl)eth-1-yl) et composes correspondants tels que les antagonistes du recepteur de la bradykinine de type b1 pour le traitement des maladies inflammatoires |
| JP2006526015A (ja) * | 2003-05-02 | 2006-11-16 | エラン ファーマシューティカルズ，インコーポレイテッド | 炎症疾患治療のためのブラジキニンｂ１受容体アンタゴニストとしての４−ブロモ−５−（２−クロロ−ベンゾイルアミノ）−１ｈ−ピラゾール−３−カルボン酸アミド誘導体および関連化合物 |
| JP2006525361A (ja) * | 2003-05-02 | 2006-11-09 | エラン ファーマシューティカルズ，インコーポレイテッド | ブラジキニンｂ１受容体アンタゴニストとしての選択された置換ピラゾール誘導体および関連化合物 |
| EP1831225A2 (fr) * | 2004-11-19 | 2007-09-12 | The Regents of the University of California | Pyrazolopyrimidines anti-inflammatoires |
| WO2007114926A2 (fr) | 2006-04-04 | 2007-10-11 | The Regents Of The University Of California | Antagonistes de la kinase |
| KR101104666B1 (ko) * | 2006-09-06 | 2012-01-13 | 에프. 호프만-라 로슈 아게 | 단백질 키나제 억제제로서의 헤테로아릴 유도체 |
| GB0619325D0 (en) | 2006-09-30 | 2006-11-08 | Univ Strathclyde | New compounds |
| GB2467670B (en) * | 2007-10-04 | 2012-08-01 | Intellikine Inc | Chemical entities and therapeutic uses thereof |
| MX2010007419A (es) * | 2008-01-04 | 2010-11-12 | Intellikine Inc | Ciertas entidades quimicas, composiciones y metodos. |
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| US8993580B2 (en) * | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
| EP2252293B1 (fr) * | 2008-03-14 | 2018-06-27 | Intellikine, LLC | Inhibiteurs de kinases, et procédés d utilisation associés |
| BRPI0915231A2 (pt) * | 2008-07-08 | 2018-06-12 | Intellikine Inc | compostos inibidores de quinase e métodos de uso |
| US20110224223A1 (en) * | 2008-07-08 | 2011-09-15 | The Regents Of The University Of California, A California Corporation | MTOR Modulators and Uses Thereof |
| US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
| CA2738429C (fr) | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Inhibiteurs heterocycliques de kinases |
| EP2358720B1 (fr) | 2008-10-16 | 2016-03-02 | The Regents of The University of California | Inhibiteurs d'hétéroarylkinase à noyau fusionné |
| US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
| JP5789252B2 (ja) | 2009-05-07 | 2015-10-07 | インテリカイン， エルエルシー | 複素環式化合物およびその使用 |
| WO2011047384A2 (fr) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Procédés d'inhibition de l'activité ire1 |
| CA2799579A1 (fr) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Composes chimiques, compositions et procedes pour modulation de kinases |
| JP2013545749A (ja) | 2010-11-10 | 2013-12-26 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環化合物及びその使用 |
| ES2637113T3 (es) | 2011-01-10 | 2017-10-10 | Infinity Pharmaceuticals, Inc. | Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas |
| US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
| AR088218A1 (es) | 2011-07-19 | 2014-05-21 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos utiles como inhibidores de pi3k |
| HK1198443A1 (en) | 2011-07-19 | 2015-04-24 | 无限药品股份有限公司 | Heterocyclic compounds and uses thereof |
| CN102952062B (zh) * | 2011-08-12 | 2016-06-08 | 中国医学科学院医药生物技术研究所 | 取代苯并杂环类化合物及其制备方法和应用 |
| MX2014002542A (es) | 2011-08-29 | 2014-07-09 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y usos de los mismos. |
| CA2846496C (fr) | 2011-09-02 | 2020-07-14 | The Regents Of The University Of California | Pyrazolo[3,4-d]pyrimidines substituees et utilisations de celles-ci |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US8921426B2 (en) | 2012-04-18 | 2014-12-30 | International Business Machines Corporation | Cationic bis-urea compounds as effective antimicrobial agents |
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
| JP2015532287A (ja) | 2012-09-26 | 2015-11-09 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | Ｉｒｅ１の調節 |
| AU2013337717B2 (en) | 2012-11-01 | 2018-10-25 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using PI3 kinase isoform modulators |
| US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| PT3052485T (pt) | 2013-10-04 | 2021-10-22 | Infinity Pharmaceuticals Inc | Compostos heterocíclicos e suas utilizações |
| MX382033B (es) | 2014-03-19 | 2025-03-13 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma. |
| WO2015160975A2 (fr) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Polythérapies |
| WO2016054491A1 (fr) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Composés hétérocycliques et leurs utilisations |
| CN104845967B (zh) | 2015-04-15 | 2020-12-11 | 苏州新海生物科技股份有限公司 | 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用 |
| CN108026027B (zh) * | 2015-08-17 | 2020-10-02 | 邱浩杰 | 经取代的丙二酰胺化合物及其作为抗菌药物的用途 |
| WO2017048702A1 (fr) | 2015-09-14 | 2017-03-23 | Infinity Pharmaceuticals, Inc. | Formes solides de dérivés d'isoquinolinone, leur procédé de fabrication, compositions les comprenant et méthodes d'utilisation de celles-ci |
| WO2017161116A1 (fr) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues de composés isoquinolinone et quinazolinone et leurs utilisations comme inhibiteurs de la kinase pi3k |
| WO2017214269A1 (fr) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Composés hétérocycliques et leurs utilisations |
| SG11201811237WA (en) | 2016-06-24 | 2019-01-30 | Infinity Pharmaceuticals Inc | Combination therapies |
| WO2018047148A1 (fr) | 2016-09-12 | 2018-03-15 | Novartis Ag | Composés pour inhibition du miarn |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| CA1308516C (fr) * | 1987-07-06 | 1992-10-06 | The Governors Of The University Of Alberta | Agents antiviraux et anticancereux oligopeptidiques |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| EP0679088B1 (fr) * | 1992-09-29 | 2002-07-10 | Inhale Therapeutic Systems | Liberation dans les poumons de fragments actifs d'hormone parathyroidienne |
| AU7380294A (en) * | 1993-08-06 | 1995-02-28 | Synphar Laboratories, Inc. | Oligopeptide antiretroviral agents |
| US5502068A (en) * | 1995-01-31 | 1996-03-26 | Synphar Laboratories, Inc. | Cyclopropylpyrroloindole-oligopeptide anticancer agents |
-
2001
- 2001-06-26 KR KR1020027017685A patent/KR20030011371A/ko not_active Withdrawn
- 2001-06-26 CN CN01811885A patent/CN1439006A/zh active Pending
- 2001-06-26 US US09/892,327 patent/US6849713B2/en not_active Expired - Fee Related
- 2001-06-26 AU AU2001270183A patent/AU2001270183A1/en not_active Abandoned
- 2001-06-26 RU RU2003101969/04A patent/RU2003101969A/ru not_active Application Discontinuation
- 2001-06-26 IL IL15311901A patent/IL153119A0/xx unknown
- 2001-06-26 BR BR0112030-1A patent/BR0112030A/pt not_active IP Right Cessation
- 2001-06-26 EP EP01948740A patent/EP1294713A2/fr not_active Withdrawn
- 2001-06-26 MX MXPA02012271A patent/MXPA02012271A/es unknown
- 2001-06-26 NZ NZ522839A patent/NZ522839A/en unknown
- 2001-06-26 JP JP2002505774A patent/JP2004501915A/ja not_active Withdrawn
- 2001-06-26 CA CA002414512A patent/CA2414512A1/fr not_active Abandoned
- 2001-06-26 WO PCT/US2001/020334 patent/WO2002000650A2/fr not_active Ceased
-
2002
- 2002-10-23 US US10/277,666 patent/US6906103B2/en not_active Expired - Fee Related
- 2002-11-28 NO NO20025720A patent/NO20025720L/no not_active Application Discontinuation
- 2002-12-02 ZA ZA200209774A patent/ZA200209774B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001270183A1 (en) | 2002-01-08 |
| US20030119749A1 (en) | 2003-06-26 |
| US6906103B2 (en) | 2005-06-14 |
| CA2414512A1 (fr) | 2002-01-03 |
| CN1439006A (zh) | 2003-08-27 |
| EP1294713A2 (fr) | 2003-03-26 |
| US6849713B2 (en) | 2005-02-01 |
| WO2002000650A2 (fr) | 2002-01-03 |
| WO2002000650A9 (fr) | 2003-03-06 |
| ZA200209774B (en) | 2004-03-02 |
| WO2002000650A3 (fr) | 2002-10-24 |
| NO20025720D0 (no) | 2002-11-28 |
| RU2003101969A (ru) | 2004-07-10 |
| BR0112030A (pt) | 2003-04-29 |
| NZ522839A (en) | 2004-11-26 |
| IL153119A0 (en) | 2003-06-24 |
| KR20030011371A (ko) | 2003-02-07 |
| MXPA02012271A (es) | 2004-09-06 |
| JP2004501915A (ja) | 2004-01-22 |
| US20020037856A1 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20025720L (no) | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet | |
| NO20023516D0 (no) | Antibakterielle 3-aminokinazolinon-2,4-dioner | |
| NO20033773L (no) | Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet | |
| DE50014425D1 (de) | Asymmetrischer, mehrstrahliger radarsensor | |
| DE60230054D1 (de) | 1h-imidazol-derivate mit cb1-agonistischer, antagonistischer oder partialer agonistischer aktivität | |
| LTPA2014008I1 (lt) | Nauji junginiai, turintys inhibuojantį aktyvumą prieš nuo natrio priklausomą gliukozės pernešėją | |
| PT1140840E (pt) | Difenilureias substituidas com (.)-carboxiarilo como inibidores de raf-quinase | |
| DE60017270D1 (de) | Serielle, lippenförmige rückschlagventile | |
| DE50213548D1 (de) | Substituierte 2-carba-3,5-dicyano-4-aryl-6-aminopylektive liganden | |
| NO20020810D0 (no) | Nye fenylpiperaziner | |
| BR0208970B1 (pt) | produto absorvente com ajuste melhorado. | |
| BR0208971B1 (pt) | produto absorvente com ajuste melhorado. | |
| BR0013417B1 (pt) | composiÇço aquosa. | |
| BR0208969B1 (pt) | produto absorvente com ajuste melhorado. | |
| NO20030100D0 (no) | Pleuromutilinderivater som har antibakteriell aktivitet | |
| PT1389213E (pt) | Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos | |
| IS8147A (is) | Nýjar línkómýsín afleiður sem búa yfir örverueyðandi virkni | |
| PT1206476E (pt) | 9a-azalidos com actividade antibacteriana | |
| NL1021302A1 (nl) | Rolschakelaar. | |
| RU2003110288A (ru) | Вещество, обладающее антидепрессивной активностью | |
| DK1268475T3 (da) | Nye benzosultam-oxazolidinoner som antibakterielle midler | |
| CL2004001026A1 (es) | COMPUESTOS DERIVADOS DE 3-DECLADINOSILO DE 9a-N-CARBAMOIL Y 9a-N-TIOCARBAMOIL-9-DEOXO-9-DIHIDRO-9a-AZA-9a-HOMOERITROMICINA A; Y PROCEDIMIENTO DE PREPARACION, UTILES COMO AGENTES ANTIBACTERIANOS. | |
| DE60112904D1 (de) | Kabelloses, eigensicheres ventil | |
| AR027978A1 (es) | 4-oxo-1,4-dihidro-3-cinolincarboxamidas como agentes antivirales | |
| NO20025101D0 (no) | Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |